Compound class:
Synthetic organic
Comment: Lolamicin is an antibacterial with potential to avoid disruption of the gut microbiota. It has specific activity against Gram-negative pathogenic bacteria, while selectively sparing Gram-negative and Gram-positive commensal strains [2]. Lolamicin is an inhibitor of lipoprotein CDE (LolCDE) [2], a complex found in the membrane of Gram-negative bacteria. It is one of the chemical structures claimed in patent WO2023091873A1 from the University of Illinois [1].
|
|
Bioactivity Comments |
Lolamicin has activity in vitro against laboratory strains of Gram-negative pathogens including Escherichia coli (MIC of 0.008-2 μg/ml), Klebsiella pneumoniae (MIC of 1-4 μg/ml) and Enterobacter cloacae (MIC of 1-4 μg/ml), but not Gram-positive pathogens or Gram-negative and Gram-positive gut commensal bacteria (MIC >128 μg/ml) [2]. |